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Programmable DNA looping using engineered
bivalent dCas9 complexes
Nan Hao 1, Keith E. Shearwin1 & Ian B. Dodd1
DNA looping is a ubiquitous and critical feature of gene regulation. Although DNA looping
can be efﬁciently detected, tools to readily manipulate DNA looping are limited. Here we
develop CRISPR-based DNA looping reagents for creation of programmable DNA loops.
Cleavage-defective Cas9 proteins of different speciﬁcity are linked by heterodimerization or
translational fusion to create bivalent complexes able to link two separate DNA regions. After
model-directed optimization, the reagents are validated using a quantitative DNA looping
assay in E. coli. Looping efﬁciency is ~15% for a 4.7 kb loop, but is signiﬁcantly improved by
loop multiplexing with additional guides. Bivalent dCas9 complexes are also used to activate
endogenous norVW genes by rewiring chromosomal DNA to bring distal enhancer elements
to the gene promoters. Such reagents should allow manipulation of DNA looping in a variety
of cell types, aiding understanding of endogenous loops and enabling creation of new reg-
ulatory connections.
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Transcription is frequently regulated positively or negativelyby the interaction of proteins bound to different sites onthe same DNA molecule. These regulatory interactions can
occur at long range (>1 kb), forming large DNA loops1–3. In
multicellular organisms, many promoters are regulated by distal
enhancer or silencer elements, sometimes separated by megabase
distances4, 5. Similarly, in bacteria, the activity of σ54-dependent
promoters can be activated by bEBPs (bacterial enhancer-binding
proteins) bound many kb away from the promoter2. Though
poorly understood, the efﬁciency and speciﬁcity of these inter-
actions appears to be controlled by other DNA looping elements.
In eukaryotes, dedicated tethering elements are used to stimulate
speciﬁc enhancer–promoter contacts6, while insulator elements
interact with each other to sequester the enhancer and promoter
into separate DNA loops7. Genome-wide chromatin capture
studies have revealed a vast number of highly speciﬁc long-range
DNA–DNA interactions, supporting a ubiquitous role of DNA
looping in gene regulation8. However, the function of most of
these DNA loops, and how these highly speciﬁc patterns of DNA
looping are achieved and modulated, remains unclear.
Engineering of artiﬁcial DNA loops provides a means to
manipulate endogenous DNA loops to better understand their
function and to modulate gene expression, potentially with
therapeutic applications, such as forming new
enhancer–promoter connections to circumvent genetic deﬁ-
ciencies or inhibiting dysfunctional enhancer–promoter contacts.
For example, fusion of the Ldb1 protein that binds to proteins at
β-globin promoters to an engineered zinc ﬁnger DNA-binding
domain able to bind to the β-globin locus control region (LCR)
was able to redirect the LCR to activate an alternative promoter9.
However, the design of zinc ﬁnger proteins able to target speciﬁc
sequences can be laborious, and in the above case the looping
reagent required a pre-existing protein–protein interaction. An
alternative approach, insertion of binding sites for heterologous
DNA-looping proteins, requires alteration of the genome
sequence. Thus, a heterologous reagent that can be readily pro-
grammed to connect any two endogenous DNA segments would
greatly facilitate DNA loop engineering.
Fusions of various protein domains to cleavage-defective Cas9
proteins (dCas9s) from bacterial CRISPR (clustered regularly
interspaced short palindromic repeat) systems have been widely
used to target speciﬁc functionalities to speciﬁc genomic DNA
sequences, directed by the sequence of the associated single guide
RNA (sgRNA)10. A bivalent CRISPR reagent that contains two
orthogonal dCas9 moieties should thus be capable of pro-
grammed binding to two DNA segments at the same time by
using two different sgRNAs. Here we design and construct such a
reagent and show that it can drive de novo DNA loops in E. coli
cells. We show that this DNA looping reagent is highly pro-
grammable and also multiplexable, readily allowing simultaneous
linking of multiple targets to promote efﬁcient DNA looping over
a ~12 kb distance.
Results
Modeling DNA looping by a bivalent dCas9 complex. Our ﬁrst
approach was to construct dCas9 heterodimers (Fig. 1a). The use
of two orthogonal dCas9s allows the DNA-binding speciﬁcity of
each dCas9 component of the heterodimer to be independently
programmed by its speciﬁc cognate sgRNA. A homodimeric
design, though simpler, has the disadvantage that half of the
homodimers would be charged with sgRNAs of the same
sequence speciﬁcity and would inhibit DNA looping. We chose
the well-studied Streptococcus pyogenes (Sp) and Streptococcus
thermophilus CRISPR1 (St) dCas9s11.
In order to optimize the efﬁciency of looping, we developed a
simple statistical mechanical model for DNA looping by a
bivalent dCas9 (Fig. 1a, b). The model indicates that the fractional
looping Floop, that is the fraction of time that the DNA loop is
formed, is critically dependent on ﬁve parameters: (1) the
dimerization of the Sp and St dCas9 monomers, given by the
dimer dissociation constant Kdim (nM); (2) the binding afﬁnity of
each dCas9–sgRNA complex for its DNA site, given by a
dissociation constant, KDNA (nM); (3) the fractional saturation of
each of the dCas9 proteins with its cognate sgRNA, θ; (4) the total
concentrations of each dCas9, [Ctot] (nM); and (5) the DNA
loopability factor J (nM), the effective relative concentration of
one target DNA site relative to the other. At distances beyond
250 bp in vivo, J is primarily dependent on the length of the DNA
loop and decreases as the loop gets larger, due to the entropic cost
of holding two distant DNA sites together12–14.
In our model, we made the simplifying assumption that KDNA,
θ, and [Ctot] are the same for both Sp and St dCas9s (Fig. 1b–e).
Looping efﬁciency depends on all ﬁve parameters, such that the
exact response of looping to changes in any one parameter
depends on the values set for the other four parameters.
Nevertheless, with the exception of dCas9 concentration, which
has a clear optimum, all the other parameters show a monotonic
effect on DNA looping (Fig. 1c).
As expected, DNA looping improves with stronger dimeriza-
tion between dCas9 monomers, such that the majority of dCas9
complexes exist in a looping competent dimer form rather than
looping-incompetent monomers (Fig. 1c). To this end, we fused
strong heterodimerizing leucine zippers15 to the C-termini of Sp
and St dCas9 (dCas9_Zip). These synthetic leucine zipper tags
contain four pairs of electrostatically attractive salt bridges,
designed to destabilize homodimer interactions and maximize
inter-helical interactions. The strong dimerization constant for
this pair, Kdim= 1.3 × 10−2 nM15, should be close to optimal for
DNA looping (Fig. 1c).
Since only sgRNA-bound dCas9 can bind the DNA target16, 17,
looping is maximized when the dCas9s are fully saturated with
sgRNA (Fig. 1c). To attempt to ensure saturation, we expressed
the Sp and St dCas9_Zip proteins from chromosomally integrated
single-copy constructs, while the sgRNAs were expressed from a
multicopy plasmid (p15a ori, 15–20 copies per cell) under the
control of a strong synthetic promoter.
Our model also predicts that DNA looping increases with
higher afﬁnity interactions between the dCas9–sgRNA complex
and its target DNA (i.e., low KDNA; Fig. 1c). There is some
uncertainty about the KDNA of Sp dCas9 in vivo. The Sp
dCas9–sgRNA complex was shown to interact strongly with a
perfectly matched DNA site in vitro, with a KDNA ~1.3 nM by
bio-layer interferometry18. However, a substantially weaker KDNA
of 68.28 nM was obtained using microscale thermophoresis19.
Furthermore, a KDNA of 105 nM was obtained by ﬁtting in vivo
repression data20. We used this in vivo estimate for the plots in
Fig. 1c–e.
The model further predicts that there exists an optimal dCas9
concentration for looping (Fig. 1c), as seen for looping by Lac
repressor13, 21. If the concentration of dCas9 is too low, then its
fractional occupation of the target DNA is sub-optimal for
looping. Conversely, if the dCas9 concentration is too high, then
both target sites will tend to be separately occupied by a dCas9
dimer (Fig. 1b, species 12−15), rather than having a single dCas9
dimer that bridges the two DNA sites. In the case where dCas9 is
fully dimerized and saturated with guide RNA, looping is optimal
when the dCas9 concentration [Ctot] is equal to its KDNA. It
follows that the lower the absolute values of KDNA (and [Ctot])
are, the greater the efﬁciency of looping (Fig. 1d). To keep the
dCas9_Zips in the concentration range where efﬁcient looping is
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01873-x
2 NATURE COMMUNICATIONS |8:  1628 |DOI: 10.1038/s41467-017-01873-x |www.nature.com/naturecommunications
possible, we used three different promoters with roughly a 25:3:1
ratio in their respective promoter strengths22 to produce a range
of dCas9_Zip concentrations.
Finally, the model shows that the maximal achievable looping
efﬁciency is also dictated by J. The plots of Fig. 1c assume J= 266
nM, which is the expected value for a 1400 bp loop based on the
empirical relationship between J and loop length obtained from
measurements of LacI and λ CI looping in E. coli cells13. The plots
of Fig. 1e show the expected maximal DNA looping for a range of
loop lengths for bivalent dCas9 of different DNA-binding
afﬁnities. For a given KDNA, DNA looping is favored with a
smaller separation (higher J values). For a given loop length (a
ﬁxed J), lower KDNA (and [Ctot]) values improve looping. This is
because looping is a competition for binding to the free target site
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Fig. 1 Modeling dCas9-mediated DNA looping. a Model parameters. Kdim dimerization constant, KDNA dissociation constant of dCas9 to DNA, J the
effective concentration of one target DNA site relative to the other, [M] concentration of dCas9 monomer, [D] concentration of dCas9 dimer, [Ctot] total
concentration of one dCas9, and θ the fractional saturation of dCas9 with its cognate sgRNA. Subscripts A and B denote two orthogonal dCas9s. b
Statistical mechanical model of DNA looping by heterodimerizing dCas9s, assuming the same parameters for each dCas9. c The effect of varying Kdim,
KDNA, θ, and [Ctot] on Floop. In each of the plots, only one parameter is changed while the others are kept constant: Kdim= 1.3 × 10−2 nM15, KDNA= 105 nM20,
θ= 1, [Ctot]= 1.05 × 102 nM, J= 266 nM at d= 1400 bp separation (J= 1.08 × 106 x d–1.15)13. For the case where [CA_tot]= [CB_tot], [M] for each dCas9 was
calculated as ((√(1 + 4[Ctot]/Kdim))–1)/(2/Kdim) and [D] as [Ctot] – [M]. d At constant KDNA, θ, and J, Floop increases when KDNA decreases. At any given
KDNA, Floop is highest when [Ctot]= KDNA (assuming complete dimerization). e At optimal dCas9 concentration ([Ctot]= KDNA), Floop is inversely related to
KDNA. At any given KDNA, the maximal Floop decreases as distance separation between two DNA sites increases (i.e., decreasing J). At [Ctot]= KDNA=
1.05 × 102 nM (marked by the red line), the maximal Floop is estimated to be 67, 48, 39, 24, 14, and 6% at 0.5, 0.8, 1.4, 2.5, 4.7, and 10 kb separation
between the two looping sites
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concentration J, and a dCas9 dimer in solution, at concentration
[D], with looping favored when J> [D] (Fig. 1a).
Testing the system components. To assess the ability of
dCas9_Zips to heterodimerize in vivo, split-GFP (green ﬂuor-
escent protein) assays23 were used. The Sp and St_dCas9_Zips
were fused with the C- or N-terminal halves of GFP, respectively
(Supplementary Fig. 2). Co-expression of plasmid-borne Sp
dCas9_Zip_GFP_C and St dCas9_Zip_GFP_N, but not any of the
individual fusion proteins alone, led to the reconstitution of a
functional GFP protein (Fig. 2a), suggesting that the Sp and St
dCas9_Zips are capable of heterodimerization in vivo.
To conﬁrm DNA binding of the dCas9_Zips in vivo,
transcriptional roadblocking assays24 were used, where dCas9_-
Zips were directed to target the 5′ UTR of the lacZ reporter gene
(Fig. 2b). The principle of this assay is that a DNA-bound
complex at a transcribed region can stall elongating RNA
polymerase (RNAP), leading to transcription termination and
reduced expression of the reporter. Strong roadblocking by dCas9
proteins has been demonstrated in E. coli, particularly when the
sgRNA targets the non-template strand25–27.
Both Sp and St dCas9_Zips expressed from the intermediate
strength promoter blocked lacZ transcription to a level compar-
able to or below that seen with ~35 nM of Lac repressor and its
high-afﬁnity lacOid operator (in vivo KDNA ~0.17 nM28) (Fig. 2c).
There was no detectable difference in roadblocking by an Sp
dCas9_Zip protein alone or Sp dCas9_Zip in the presence of its
heterodimerizing partner protein St dCas9_Zip. However, road-
blocking by Sp dCas9_Zip was ~sixfold weaker than that of wt Sp
dCas9 when expressed from the same intermediate strength
promoter, potentially due to its twofold reduced expression level
(Fig. 2d). In contrast, roadblocking by St dCas9 and its Zip fusion
(+heterodimerizing partner) was similar when expressed from the
intermediate strength promoter. As expected, roadblocking by the
dCas9_Zips was relatively insensitive to the two different but fully
complementary spacer sequences tested, however, roadblocking
was strongly affected by the expression levels of dCas9_Zips. At
the high expression level, both Sp and St dCas9_Zips were capable































1 110 10100 1001000 1000
Int


















































































Fig. 2 Characterization of the system components. a Split-GFP assay conﬁrming heterodimerization of Sp and St dCas9_Zip in vivo. b Schematic of the
chromosomally integrated roadblocking reporter constructs (see also Supplementary Fig. 1). The relative positions of sgRNA-targeting sites are marked
with lines. The PAM proximal end is boxed. c Roadblocking readthrough across lacOid with 35 nM LacI or dCas9 target sites with various concentrations of
wt (unshaded) or Zip fusion (shaded) dCas9s. Both Sp and St dCas9s were expressed from chromosomally integrated expression modules under the
control of low, intermediate (Int), or high strength promoters. Readthrough values are calculated as steady state LacZ units obtained in the presence of
roadblock proteins (LacI or dCas9) divided by the activity in their absence. Thus, readthrough= 1 when there is no roadblocking, and readthrough= 0 when
there is complete roadblocking. Data are mean± 95% conﬁdence intervals (n= 9). d qRT-PCR showing the relative expression level of the wt (unshaded)
and Zip fusion (shaded) dCas9 under the control of low, intermediate, and high strength promoters. The E. coli gyrA gene was used as a reference gene for
data normalization and the rho gene was used as an internal control. Data are mean± standard error (n= 3) and are expressed as a ratio relative to the
intermediate expression level of dCas9_Zip. e Roadblock readthrough at different sgRNA expression levels. The relative expression levels are 1:21:256:
~2500, with the strongest promoter being J23119 (Biobricks, http://parts.igem.org/Part:BBa_J23119)
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expression level, Sp and St dCas9_Zips gave only 5–15% and
~30% roadblocking, respectively (Fig. 2c).
In addition, transcriptional roadblocking assays also conﬁrmed
that both Sp and St dCas9_Zips were saturated with their cognate
sgRNAs, as roadblocking was not decreased even when the
promoter expressing the sgRNAs was weakened ~2500-fold
(Fig. 2e and Supplementary Fig. 2).
The dual-dCas9 complex is capable of looping DNA in vivo. To
test whether our engineered bivalent dCas9_Zip complex was
capable of looping DNA, chromatin conﬁguration capture (3C)
assays were performed. The dCas9_Zip heterodimers were
expressed from an intermediate strength promoter, and paired
with either T4 + S3 or T4 + Ctl sgRNAs (Fig. 3). In contrast to T4
+ Ctl control, where the dCas9_Zip heterodimers were only
localized to the chromosomal DNA by a single site, targeting
dCas9_Zip to both T4 and S3 sites signiﬁcantly increased the
contact frequency between these two sites, 1.7 kb apart, demon-
strating the formation of a dCas9_Zip-mediated DNA loop
between these two sites. However, while the 3C assay is com-
monly used to demonstrate looping between two regions of
DNA9, 29, it does not give a quantitative measure of looping
efﬁciency.
To answer this question, we turned to a second in vivo looping
assay, based on our previous demonstration that a DNA loop
nested inside another DNA loop can assist the outer loop’s
formation14, 30. Loop assistance occurs because looping between
the two internal sites reduces the effective distance between the
two outside sites, making them more likely to interact with each
other (Fig. 4a).
We designed pairs of Sp and St sgRNAs that targeted two DNA
sites about 1.4 kb apart from each other within a 2.1 kb LacI
looping reporter (Fig. 4b). The formation of a LacI-mediated loop
between the distal lacOid-binding site and the
promoter–proximal lacO2 site can be detected by its effect on
promoter repression13, 28, 30, 31. In the absence of an upstream
operator, LacI binds weakly to the lacO2 operator, leading to
partial repression of the lacZ promoter at the low [LacI] used. In
the presence of the strong distal lacOid operator, LacI bound at
that site can interact by DNA looping to simultaneously occupy
the lacO2 site, increasing total lacO2 occupancy and promoter
repression (Supplementary Fig. 3A, B). By comparing promoter
activity in the presence or absence of the distal site, it is possible
to determine the absolute fraction of LacI looping FLac13. Loop
assistance due to looping between the internal sites increases FLac
and is revealed by increased LacI-mediated repression of the
reporter14, 30.
As shown in Fig. 4b, a consistent decreased expression of the
reporter was observed for all couplings of the bivalent dCas9_Zip
and speciﬁc Sp and St sgRNAs targeting two internal DNA sites
(T2 + S1, T3 + S1, T2 + S2, and T3 + S2). In contrast, targeted
wild-type Sp and St dCas9 proteins did not affect reporter activity.
Expression of the bivalent dCas9_Zip with control sgRNAs,
targeting either no internal site or any single internal site, also did
not affect the reporter (Fig. 4b). Similarly, a further set of control
experiments in which the reporter DNA was altered to remove all
but one dCas9 target site (Supplementary Fig. 4), conﬁrmed that
two targeted DNA sites were needed for the effect. This
dependence on each of the components required for dCas9-
mediated looping—the targeted DNA sites, the correct sgRNAs,
and the heterodimerizing dCas9-Zips—shows that the decreased
reporter activity is due to dCas9 looping.
As expected from our model, the degree of loop assistance
changed with different expression levels of the dCas9_Zips. In all
cases, the dCas9 loop was most readily formed with the
intermediate expression level, enhancing FLac from 73± 3%
(95% conﬁdence intervals, n= 9) to 83± 2%. A model for loop
assistance30 estimates that this improvement in LacI looping is
equivalent to ~40% looping by dCas9 alone (Fig. 4c and
Supplementary Fig. 3D), which corresponds well with the 40%
maximal looping expected from our dimeric dCas9 model
(Fig. 1e). Higher expression levels did not increase loop assistance
further, despite showing a stronger roadblocking effect in the
roadblock assay (Fig. 2c), suggesting that the dCas9_Zip
concentration begins to exceed its optimum (Fig. 1c), which
leads to each of the looping sites being occupied by a separate
dCas9_Zip dimer and consequent loop breakage. Loop assistance
at the lowest expression level of dCas9_Zip heterodimer only
slightly increased lac loop formation to 77± 2% (Fig. 4b),
consistent with a low occupation of target DNA at this
concentration (Fig. 2c).
The result also showed that at all three dCas9 expression levels,
similar loop assistance was observed when the two halves of a
dCas9_Zip dimer targeted either the same strand of DNA or
opposite strands of the DNA (Fig. 4b, e). This ﬂexibility increases
the programmability of the system, as PAM sequences on either
DNA strand can be utilized as valid target sites.
To further examine this programmability of looping, we
designed two St sgRNAs that bind ~150 and 290 bp downstream
of the distal lacOid operator, and paired each of them with either
control Sp sgRNA or one of ﬁve speciﬁc Sp sgRNAs that target
within a ~300 bp window upstream of the placUV5 promoter
(loop sizes for the dCas9 loops ranging from 1400 to 1870 bp).
Using the intermediate expression level of the dCas9_Zips, we
showed that DNA looping is extremely robust, with all
combinations of speciﬁc Sp and St sgRNAs consistently assisting
the formation of a 2.1 kb lac loop from ~73 to 82% (Fig. 4e).
DNA looping by an Sp_St_dCas9 fusion. An alternative
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Fig. 3 Assaying dCas9-mediated looping via chromosome conformation
capture (3C). Relative contact frequencies between the anchor fragment
(solid black line) and four of the BsaWI restriction digest fragments (dotted
gray lines) were assessed by qPCR, and plotted as the ratio between cells
expressing a pair of speciﬁc sgRNAs (T4 + S3) and cells expressing only
one speciﬁc sgRNA (T4 + Ctl). The sgRNA T4 is the guide RNA that
localizes dCas9_Zip heterodimer to the anchor fragment. Data are mean±
standard deviation (n= 3). The DNA region of interest is shown below the
plot, with the dCas9 target sites highlighted, and the BsaWI restriction sites
indicated by short black bars. Orange arrowheads above the plot indicate
the qPCR primer sites
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dCas9 monomers together as a single polypeptide, in effect
making the dimerization inﬁnitely strong (Fig. 1c). To test DNA
looping by this alternative design, we joined the two proteins by a
15 amino acid ﬂexible linker, and expressed it from a medium
copy plasmid (CloDF13 ori, 20–40 copies per cell) under the
control of strong, intermediate, and weak promoters. The need
for plasmid-based expression and the different expression pro-
moter response compared to the dCas9_Zips probably reﬂects
difﬁculties in expressing the 2504 amino acid fusion protein. In
the loop assistance assay, DNA looping by this fusion dCas9 was
able to increase F for a 2.1 kb lac loop from 72± 3 to 82± 2%
(Supplementary Fig. 5), similar to that achieved with the Sp + St
dCas9_Zip heterodimer. DNA looping by the fusion protein was
strongest when expressed from the weak pro1 promoter, followed
by the intermediate proA promoter, and was weakest with the
strong proC promoter (Supplementary Fig. 5), suggesting that the
expression level from both intermediate and strong promoters
exceeds the optimum for looping (Fig. 1c).
Enhancing DNA looping via dCas9-mediated loop multi-
plexing. We have demonstrated that both Sp+ St dCas9_Zip
heterodimers and Sp_St dCas9 fusions were able to form DNA
loops within a 2.1 kb LacI loop to assist lac loop formation from
~73 to 83% (Fig. 3b and Supplementary Fig. 5). However, loop
assistance by the dCas9 complexes was relatively weak, as at this
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Fig. 4 Assaying dCas9-mediated looping via loop assistance. a Basic principle of the loop assistance assay. b Formation of the CRISPR loop assists
formation of the LacI loop. Floop is calculated as [(LacZOD––bkgd) – (LacZOD+–bkgd)]/(LacZOD––bkgd) (Supplementary Fig. 3A–C). The measured average
LacZOD– values for wt as well as different concentration of Sp/St dCas9_Zip fusions were 578± 17, 549± 18, 541± 22, and 567± 30, respectively. Data
are mean± 95% conﬁdence intervals (n= 9). A bkgd value= 16 units (unrepressible LacZ background) is estimated13. All Floop values are mean± standard
deviations (n= 9). c, d The F for the CRISPR loop alone, FdCas9, can be calculated from the observed LacI looping in the presence of dCas9, FLacI(dCas9), by
applying a loop assistance factor equivalent to the distance shortening due to the formation of the internal loop30. e The formation of the CRISPR loop is
relatively insensitive to the spacer sequences used. Data are mean± 95% conﬁdence intervals (n= 9)
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alone. Even if the dCas9 loop were to form 100% of the time, the
maximal looping expected for the lac loop would be 89% (Fig. 4c).
To test the effectiveness of our CRISPR looping reagents over a
larger distance, we employed an additional chromosomally inte-
grated lacZ reporter with a lacOid operator 5.6 kb upstream of the
lacO2 operator (Fig. 5a). Thus, looping sizes for sgRNAs S7 + T5,
and S8 + T6 are both around 4.7 kb.
As expected, DNA looping by LacI alone becomes much
weaker at 5.6 kb, at only ~34± 5%, consistent with our previous
ﬁndings13. Loop assistance by a single pair of Sp and St sgRNAs
combined with either Sp+ St dCas9_Zip heterodimer or Sp_St
dCas9 fusion increased LacI looping (Fig. 5c). Similar to the
previous results (Fig. 4b and Supplementary Fig. 5), loop
assistance was strongest for the Sp + St dCas9_Zip heterodimers
expressed from a single-copy intermediate strength promoter,
and for the Sp_St dCas9 fusions expressed by a weak promoter
from a medium copy number plasmid. When expressed at their
optimal concentrations, both Sp+ St dCas9_Zip heterodimer and
Sp_St dCas9 fusion improved the LacI looping from ~34 to 47%.
Applying a similar analysis to that used in Fig. 4c, we estimate
that the bivalent dCas9 is alone capable of ~17% looping at a 4.7
kb distance (Fig. 4d and Supplementary Fig. 3D). This is again
consistent with the ~14% maximal looping at this distance
predicted from our dimeric dCas9 model (Fig. 1e).
In addition, the ability of the DNA-binding speciﬁcity of each
dCas9 element to be independently programmed allows for the
possibility of increasing overall loop efﬁciency by creating
multiple loops simply by expressing multiple sgRNAs. To test
this multiplexibility, we simultaneously expressed two sgRNAs for
each dCas9, which should allow the dCas9 looping reagent to
form four different single loops and two possible double loops
(Fig. 5b). Each of these nested looping species should assist the
formation of the outside LacI loop. Indeed, expression of all four
sgRNAs in the 5.6 kb reporter was able to increase lac looping
~1.7-fold to ~58% (Fig. 5c), a substantial improvement from the
single dCas9-mediated loop assistance.
The dual-dCas9 loops improves enhancer–promoter contact.
As an independent assay for bivalent dCas9-mediated DNA
looping, a classical bacterial promoter–enhancer interaction
model32 was adapted. Here a σ54-dependent glnAp2 promoter
was used to drive the expression of a chromosomally integrated
lacZ reporter gene. The activity of glnAp2 is regulated by the
NtrB-NtrC bacterial two-component signal transduction system.
The NtrB is both a kinase and a phosphatase, which regulates the
phosphorylation status of NtrC. Phosphorylated NtrC is a tran-
scriptional activator that binds to enhancer elements and interacts
with σ54-RNAP bound at the promoter to catalyze its transition
to the open complex33 (Fig. 6a). The kinase/phosphatase activity
of NtrB is normally controlled by the carbon and nitrogen status
of the cell. A single mutation of NtrB (A129T) signiﬁcantly
reduces the phosphatase activity of NtrB without affecting its
kinase activity, resulting in constitutively active NtrC34. Here we
used recombineering to introduce the A129T mutation into the
endogenous NtrB gene (glnL) and showed that the expression of
glnAp2 driving the lacZ reporter gene is strictly dependent on the
presence of the NtrC enhancer element. As expected, as the
separation between the enhancer and the promoter is increased,
the effect of the enhancer diminishes (Fig. 6b). When placed 11.7
kb away from the promoter, the effect of the enhancer site is only
~2% of that seen when it is placed ~300 bp away.
However, this enhancer-mediated reporter gene activation can
be signiﬁcantly increased when the enhancer site is brought closer
to the promoter using either the Sp + St dCas9_Zip heterodimer
or the Sp_St_dCas9 fusion (Fig. 6c, d). The effect of bivalent
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Fig. 5 Long-range DNA looping can be enhanced via dCas9-mediated loop multiplexing. a Schematic representation of the 5.6 kb loop assistance reporter,
with the relative positions of the sgRNA-binding sites highlighted. b Possible arrangements of CRISPR loops in the presence of four guide RNAs. c Single or
multiplexed CRISPR loops formed by heterodimerizing dCas9_Zip complexes or the Sp_St dCas9 fusion can increase LacI looping efﬁciency. Data are mean
± 95% conﬁdence intervals (n= 9). Floop values are mean± standard deviations (n= 9)
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supplied and this effect increased to ~threefold with dual-dCas9-
mediated loop multiplexing using four speciﬁc sgRNAs (Fig. 6c,
d). Similar results were also obtained at a 11.7 kb separation
between the enhancer and promoter sites (Fig. 6c, d). In contrast,
when only one speciﬁc sgRNA is expressed (together with a
control sgRNA), binding of bivalent dCas9 to the
promoter–proximal site without making a distal site contact did
not lead to increased lacZ expression, conﬁrming that the
increased glnAp2 transcription is a result of bivalent dCas9-
mediated DNA looping.
To test whether the CRISPR looping reagents could also be
used to regulate a σ54-dependent promoter at its endogenous
locus, we inserted an NtrC enhancer element 2 kb upstream of the
norVW promoter in the NtrB(A129T) strain, and designed a pair
of sgRNAs that targeted two DNA sites about 1 kb apart located
between the enhancer and the promoter (Fig. 7a). Again, if the
bivalent dCas9 complex is capable of looping DNA, it will bring
the enhancer site closer to the promoter, and should increase
promoter activation (Fig. 7b). The endogenous enhancer for the
norVW promoter is not expected to be active under the growth
conditions used, and insertion of the active NtrC enhancer gave
~10-fold activation of norVW transcription (Fig. 4c). More
importantly, the formation of the dCas9 loop between the
enhancer and promoter further increased the norV and norW
gene expression by ~twofold, suggesting that the bivalent dCas9-
based programmable DNA looping reagent is capable of looping
DNA in vivo to modulate endogenous gene expression.
Discussion
In this study, we demonstrated that engineered bivalent dCas9
complexes, consisting of heterodimerizing dCas9s from S. pyo-
genes and S. thermophilus or a translational fusion of these two
proteins, were capable of driving DNA loop formation in vivo.
The efﬁciency of DNA looping was estimated at ~40 and 17% at
1.4 and 4.7 kb, respectively. DNA looping was further improved
by multiplexing (Figs. 4c and 5d). For example, formation of two
dCas9-mediated loops, using four sgRNAs, signiﬁcantly increased
a 11.7 kb enhancer–promoter interaction, leading to ~threefold
activation of reporter gene expression (Fig. 6d). The improvement
in DNA looping with loop multiplexing suggests that higher
efﬁciencies and longer distance DNA looping could be achieved
by programming even more target sites.
It may also be possible to improve the efﬁciency of formation
of individual loops by modifying the bivalent dCas9 reagents. Our
modeling and data suggest that looping by our dCas9 reagents is
unlikely to be limited by a lack of sgRNA charging, poor
dimerization, or non-optimal concentration. Rather, the fairly
weak KDNA value of 105 nM for dCas9–sgRNA DNA binding
in vivo, obtained from an independent estimate for Sp dCas920
and consistent with our data, is likely to be limiting (Fig. 1d, e).
Stronger DNA binding by the dCas9–sgRNA elements, together
with lower dCas9 concentrations, should produce large
improvements in looping efﬁciency (Fig. 1d). One potential
avenue for improving binding is to explore different dCas9_Zip
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Fig. 6 dCas9-mediated DNA looping can be used to foster bacterial enhancer–promoter communication. a An NtrC hexamer bound at a distal enhancer
element can interact with σ54-RNAP bound at the promoter to active gene transcription. b The activation effect of NtrC decreases as the distance between
the enhancer and the promoter is increased. Data are mean± 95% conﬁdence intervals (n= 9) with the background activity in the absence of the enhancer
element subtracted. c Schematic representation of the 5.6 and 11.7 kb looping reporter used for testing dCas9-mediated promoter–enhancer activation. d
Single or multiplexed CRISPR loops formed by heterodimerizing dCas9_Zip complexes or the Sp_St dCas9 fusion increase glnAp2 transcription by looping
out DNA between enhancer and promoter. Data are mean± 95% conﬁdence intervals (n= 9). Numbers indicate fold activation relative to control sgRNAs,
with 95% conﬁdence limits in brackets
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CRISPR-Cas proteins, e.g., SaCas9, Cpf1, or C2c135–37, that may
bind DNA more strongly than the Sp and St dCas9s. A third
approach could be to mutate dCas9 to increase DNA-binding
afﬁnity. Structural studies of Cas9 in complex with sgRNA and
target DNA indicate that the binding energy of the complex
includes both sequence-speciﬁc and non-speciﬁc contributions38,
39. Recently, two independent reports showed that the non-
speciﬁc Cas9–DNA interactions can be reduced by mutating
hydrophilic amino acids that stabilize the non-target DNA
strand40 or that contact the phosphate backbone of the target
DNA strand41. Thus, it may be possible to take the reverse
approach and introduce hydrophilic amino acids to strengthen
non-speciﬁc DNA interactions, and thus overall DNA binding.
For example, the Sp Cas9 S845K and L847R mutations, which
decrease speciﬁcity40, may strengthen DNA binding. An increase
in off-target binding may not be problematic for looping appli-
cations, since increased speciﬁcity is provided by the requirement
for two DNA targets.
Given the demonstrated cross platform compatibility of
CRISPR-Cas techniques42–45, we envisage that our CRISPR
looping reagents will be readily transferable to other bacterial and
eukaryotic systems. The programmability of the CRISPR DNA
looping reagents may be readily expanded by substituting either
or both the S. pyogenes and S. thermophilus dCas9_Zips with
other dCas9 proteins with different PAM speciﬁcities, as long as
these proteins are orthogonal with regard to binding guide RNA
and exhibit strong DNA binding. Indeed, while our manuscript
was under revision, a related paper29 has demonstrated the fusion
of dCas9 from S. pyogenes and S. aureus with ligand-inducible
heterodimerization tags from the plant phytohormone S-
(+)-abscisic acid signaling pathway, and showed that dCas-
mediated DNA looping can be used to re-establish β-globin gene
expression in K562 human erythroleukemia cells by bringing the
LCR to the β-globin promoter. Thus, dCas9-mediated looping
works in both prokaryotic and eukaryotic settings.
In addition, bivalent dCas9 reagents have potential applications
beyond engineering DNA loops. They could be used to bring
together separate DNA molecules in order to improve DNA
repair or DNA insertion—for example, after cleavage mediated by
active Cas. Also, a bivalent Cas9 reagent will have a higher afﬁnity
for its DNA targets compared to a monovalent Cas9, as long as
the two target sites are close enough to favor simultaneous
binding, since dimerization and DNA looping generates coop-
erative binding. Thus, a dCas9–Cas9 bivalent reagent where the
uncleaved and cleaved target sites are near to each other could
provide a simple way to improve the efﬁciency of on-target DNA
cleavage without causing increased off-target cleavage, a major
issue for CRISPR-based genome editing46–48. The speciﬁcity of
genomic targeting of transcription-regulating domains
using dCas9 fusions10 is also likely to be improved by
use of bivalent dCas9–dCas9 reagents targeted to two nearby
DNA sites.
Methods
Bacterial strains. EC100D mcrA Δ(mrr-hsdRMS-mcrBC) φ80dlacZΔM15 ΔlacX74
recA1endA1 araD139 Δ(ara,leu)7697 galU galK λ– rpsL nupG pir+ (DHFR) (Epi-
centre) was used for propagation of R6γK ori (pir-dependent) plasmids. Other
plasmids were propagated in DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169
recA1endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1.
E4643 is BW30270 (MG1655 rph+) with the endogenous lacIZYA locus
(EcoCyc MG1655: 360, 527–366,797) removed by recombineering using
a 90bp oligonucleotide that targets the lagging strand of the replication fork, with
45bp of homology either side of the deletion site. The successful recombinant was
selected as a white colony on an LB agar plate containing X-gal (20 μg mL-1), and
the sequence across the deletion junction veriﬁed49. The parental strain for
roadblocking assays, 3C assays, and loop assistance assays was AH4213, a
derivative of E4643, with a LacI expression module consisting of the native PlacI
promoter and lacI gene, integrated at the primary bacteriophage 186 attB site
(Supplementary Fig. 1B).
The parental strain for enhancer activation assays was E. coli strain AH5244, a
derivative of E4643 containing the glnL:A129T mutation (also known as NRII2302)
generated by scarless recombineering50. Brieﬂy, the wild type glnL gene in E4643
was ﬁrst disrupted by insertion of a kanR-PrhaB-tse2 module containing a
kanamycin resistance gene and a rhamnose inducible PrhaB promoter driving the
tse2 toxin gene, and selected on LB agar plate supplemented with 2% glucose and
kanamycin (20 μg mL-1). A second round of recombineering was then performed
with a 90bp oligonucleotide that harbours glnL:A129T mutation, and counter-
selected on 1.5% M9 minimal medium (M9MM) agar supplemented with 2 mM
MgSO4, 0.1 mM CaCl2, and 0.2% rhamnose. The successful recombinant strain was
sequence veriﬁed.
DNA construction. DNA constructions used commercial DNA synthesis (Inte-
grated DNA Technologies, GenScript), restriction enzyme-based cloning, and
isothermal Gibson assembly. All sequences are available on request.
The reporter and expression constructs were made using a plasmid integration
system developed from the CRIM plasmid series51. As in the CRIM system,
transiently expressed phage integrase proteins were used to integrate the plasmids
into phage attachment sites in the bacterial chromosome. Integration was at λ attB
(EcoCyc MG1655 sequence position: 806551), φHK022 attB (position 1055419),




































Fig. 7 dCas9-mediated chromosome rewiring of an endogenous gene. a
Schematic illustration of the gutRQ-norRVW loci of the engineered E. coli.
Recombineering was used to replace the gutQ-norR genes with a module
containing NtrC enhancer-binding sites and a kanamycin selection cassette
(yellow). Gray boxes represent endogenous genes. b The principle of the
rewiring experiment. Bivalent dCas9-mediated loop assistance is expected
to bring the NtrC sites closer to the σ54-controlled norVW promoter,
leading to improved activation. c qRT-PCR showing the relative expression
levels of the norV, norW, and rho genes in the wild-type (unshaded) or
engineered (shaded) E. coli strains, either in the presence or absence of
speciﬁc sgRNAs. Improved activation of the norV and norW genes (but not
the rho control gene) is seen only when both speciﬁc guides are present.
The E. coli gyrA gene was used as a reference gene for data normalization.
Data are mean± standard error (n= 3) and are expressed as a ratio relative
to the engineered strain in the absence of sgRNAs. Asterisk indicates p<
0.05 evaluated by a paired one-tailed Student’s t test on the log10
transformed data
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PCR was used to screen for correct single-copy integrants52. Insertions
into the bacterial chromosome by recombineering utilized the pSIM6
plasmid53.
Reporter constructs. All roadblocking assay reporters (Supplementary Fig. 1)
were derived from pIT3-CL_λpL_lacOid_lacZ*(O2−)24, an integratable plasmid
carrying a λ phage pL promoter (−73 to +90), a lacOid operator (centered at +113
position), and an RNaseIII cleavage site upstream of a lacO2− lacZ reporter gene.
The lacZ* gene carries a weakened ribosome-binding site (nucleotides at positions
+289, +302, and +304 were mutated from C, T, C to A, G, and G, respectively). To
assay the ability of Sp and St dCas9 or dCas9_Zip to bind DNA, the 20 bp lacOid
operator was replaced by a synthetic DNA sequence containing protospacers for
(1) Sp sgRNA S1 and St sgRNA T1; (2) Sp sgRNA S2; and (3) St sgRNA T2 on the
non-template strand.
All looping reporters (Supplementary Fig. 1) used in the loop assistance
experiments were as Priest et al.13, described brieﬂy below:
The 300 bp–5.6 kb enhancer reporters and enhancer-minus controls used in the
enhancer activation experiments (Supplementary Fig. 1) were derived from those of
Priest et al.13, by replacing the PlacUV5 promoter with the E. coli glnAp2 promoter
(−36 to +21), and replacing the lacOid operator with an enhancer module
comprising the ﬁrst and the second NtrC sites of glnA (−100 to −151).
All lacZ reporters were integrated into the host chromosome at the λ attB site
with chloramphenicol (20 μg mL−1) selection.
The 11.7 kb NtrC activation reporter (Supplementary Fig. 1) was generated in
two steps. First, an enhancer-minus pIT-HF-CL_glnAp2_lacZ*(O2−) reporter was
integrated into the host chromosome at the λ attB site. Second, the NtrC enhancer
was inserted into a kanamycin resistance module ﬂanked by transcription
terminators54 in a pUC57 plasmid, and a derived PCR product was inserted into
the gap region between the moaA and ybhK genes (EcoCyc MG1655:
816,719–816,720) by recombineering with kanamycin (20 μg mL−1) selection.
Sp dCas9 and dCas9_Zip expression constructs. The catalytically inactive S.
pyogenes dCas9 was PCR ampliﬁed from pdCas9-bacteria (Addgene plasmid #
44249) and assembled together with a proA promoter22 into the pIT3-SH inte-
gration plasmid (Supplementary Fig. 1). Heterodimerizing Sp dCas9_Zip was
constructed by fusing an engineered 43 amino acid (a.a.) long coiled-coil peptide
(EE12RR345L) containing ﬁve leucine zipper heptad repeats15 at the C terminus of
Sp dCas9, connected via an 8 a.a. GGGGSGGR linker. To vary the expression levels
of Sp dCas9_Zip, the proA promoter was replaced with either the proC or pro1
promoter22. Single-copy integrants of pIT3-SH_proA_Sp dCas9, pIT3-SH_proC_Sp
dCas9_Zip, pIT3-SH_proA_Sp dCas9_Zip, and pIT3-SH_pro1_Sp dCas9_Zip at
the φHK022 attB site were selected with 20 μg mL−1 spectinomycin and used to
provide different concentrations of wild-type or heterodimerizing Sp dCas9.
St dCas9 and dCas9_Zip expression constructs. The catalytically inactive S.
thermophilus CRISPR1 dCas9 was PCR ampliﬁed from DS-ST1casN- (Addgene
plasmid # 48659) and assembled together with the proA promoter22 into the pIT4-
KT integration plasmid (Supplementary Fig. 1). Heterodimerizing St dCas9_Zip
was constructed by fusing an engineered 43 a.a. long coiled-coil peptide
(RR12EE345L)15 at the C terminus of St dCas9 with an 8 a.a. GGGGSGGR linker.
The (EE12RR345L) and (RR12EE345L) leucine zipper pair15 were designed to form
very stable heterodimers, while minimizing homodimer formation.
To vary the expression levels of St dCas9_Zip, the proA promoter was replaced
with either the proC or pro1 promoter22. Single-copy integrants of pIT4-KT_proA_St
dCas9, pIT4-KT_proC_St dCas9_Zip, pIT4-KT_proA_St dCas9_Zip, and pIT4-
KT_pro1_St dCas9_Zip at the φP21 attB site were selected with 20 μgmL−1
kanamycin and used to provide different concentrations of wild-type or
heterodimerizing St dCas9. The kanamycin resistance gene cassette was subsequently
removed using Flp recombinase supplied from the pE-FLP plasmid52.
Split-GFP constructs. The pSp dCas9_Zip_gfp_C plasmid (Supplementary Fig. 2)
was constructed by three-fragment Gibson isothermal assembly consisting of the
proC promoter Sp dCas9_Zip fragment ampliﬁed from pIT3-SH_proC_Sp
dCas9_Zip (see above), a gBlock fragment (IDT) carrying the C-terminal half (a.a.
158–238) of a folding reporter GFP (frGFP)23 with a 6 a.a. TSGGSG linker, and a
fragment carrying a CloDF13 ori and a spectinomycin resistance gene obtained by
PCR ampliﬁcation from the DS-ST1casN- plasmid.
The complementary pSt dCas9_Zip_gfp_C plasmid (Supplementary Fig. 2) was
made by ﬁrst linearizing the DS-ST1casN- plasmid with FspAI/FseI and assembling
with a gBlock (IDT) containing an engineered RR12EE345L leucine zipper15 and the
N-terminal half (a.a. 1–157) of the frGFP joined via a 6 a.a. TSGGSG linker. This
construct was then re-digested with KpnI/FseI to replace the CloDF13 ori and
spectinomycin resistance gene cassette with a p15a ori and kanamycin resistance
gene cassette ampliﬁed from the pUHA-1 plasmid (gift from H. Bujard, Heidelberg
University, Germany).
Sp_St dCas9 fusion expression construct. The Sp_St dCas9 fusion expression
construct pProC_Sp_dCa9s_St_dCas9 (Supplementary Fig. 2) was derived from
pSp dCas9_Zip_GFP_C by replacing the C-terminal Zip-GFP_C fusion with St
dCas9, which had been PCR ampliﬁed from DS-ST1casN-, using primers designed
to join Sp and St dCas by a 15 a.a. (GGGGS)3 ﬂexible linker55. To vary the
expression levels of the Sp_St dCas9 fusion, the proC promoter was replaced by
either the proA or pro1 promoter22.
Dual-sgRNA expression constructs. The pDual-sgRNA expression construct
(Supplementary Fig. 2) was derived from pgRNA-bacteria (Addgene plasmid #
44251). First, a module consisting of an engineered promoter (BioBrick part
BBa_J23119) driving expression of a St sgRNA scaffold (the St1m1 variant)11,
followed by synthetic tandem T3 early and T7 early terminators54, was inserted
into the AatII/EcoRI sites of pgRNA-bacteria. The inserted St sgRNA expression
module was placed in a divergent orientation relative to a similar Sp sgRNA
expression module and was separated from the Sp sgRNA expression module via
strong M13 central and λ tR2 terminators54. Second, the high copy number ColE1
ori of pgRNA-bacteria plasmid was replaced by the medium copy number p15a ori.
To vary the expression levels of the Sp and St sgRNAs, the strong J23119 promoter
was replaced by J23114, J23113, or J23112 promoters, respectively. All spacer
sequences used in this study are listed in Supplementary Table 1.
Multiplex sgRNA expression constructs. The quadruplicate sgRNA expression
construct (Supplementary Fig. 2) was derived from pDual-sgRNA by ﬁrst intro-
ducing a unique NotI site between p15a ori and the ampicillin resistance gene
cassette. This pDual-sgRNA_NotI plasmid was linearized at NotI, and re-
circularized by using Gibson assembly to incorporate a second Sp sgRNA + St
sgRNA expression module, ampliﬁed from pDual-sgRNA.
Minimal medium LacZ assays. Microtiter plate-based LacZ assays were carried
out as previously described24. Brieﬂy, cultures were grown in microtitre plates in
M9MM supplemented with 2 mM MgSO4, 0.1 mM CaCl2, 0.01 mM (NH4)2Fe
(SO4)2, and 0.4% glycerol. After reaching mid-log phase, 20 μl of culture was
combined with buffer containing (per well) 30 μL of M9MM, 150 μL of TZ8 (100
mM Tris-HCl, pH 8.0, 1 mM MgSO4, 10 mM KCl), 40 μL of ONPG
(o-nitrophenyl-β-D-galactoside 4 mgmL−1 in TZ8), 1.9 μL of 2-mercapoethanol,
and 0.95 μL of polymyxin B (20 mgmL−1; Sigma). Assays were performed in
triplicate from independent colonies and repeated on at least three different days
(n= 9).
Chromosome conformation capture assays. The 3C assays were performed as
previously described56 with slight modiﬁcations. Brieﬂy, 500 μL of OD600 ~0.6
bacterial culture, grown in M9MM, was cross-linked with formaldehyde (1% ﬁnal
v/v) for 30 min at room temperature, followed by 30 min on ice, and then quen-
ched with glycine (125 mM ﬁnal). Cells were collected by centrifugation, washed
twice with 1 mL M9MM, and lysed with 30 μL 25 mgmL−1 lysozyme (Sigma-
Aldrich, L6876) at room temperature for 10 min. Ten percent SDS was subse-
quently added to a ﬁnal concentration of 0.5% and incubated with the lysed cells
for further 10 min. Five microliters of this cell lysate were then added to 47 μL of
digestion mix (5.3 μL 10x New England Biolab (NEB) Buffer 2, 5.3 μL 10% Triton
X-100, and 35 μL MQ water), and incubated at room temperature for further 10
min before 2.4 μL of BsaWI (NEB, 10 units per μL) was added. Cell lysate was
digested at 60 °C for 1 h. Following digestion, 10% SDS was added to a ﬁnal
concentration of 0.9% and the solution incubated at room temperature for 10 min.
The whole digestion reaction was then added to a ligation mix consisting of 74.5 μL
10% Triton X-100, 0.13 μL 10 mgmL−1 bovine serum albumin, 5.3 μL 10 mM ATP,
76.3 μL 10x T4 DNA ligase buffer, 603 μL MQ water, and 1 μL of 2000 units per μL
NEB T4 DNA ligase. Ligation was carried out at 16 °C for 24 h. Following ligation,
0.5 M EDTA was added to a ﬁnal concentration of 10 mM. Cross-links were
reversed via the addition of 2.5 μL of 20 mgmL−1 Proteinase K (Sigma-Aldrich,
P6556) and an overnight incubation at 16 °C. DNA was puriﬁed via two rounds of
phenol-chloroform-isoamyl alcohol extraction (Sigma-Aldrich, P2069) and a single
round of ethanol precipitation. The typical yield was 50 ng μL−1 in 50 μL of MQ
water. The relative contact frequencies between the anchor fragment and various
BsaWI restriction digest fragments were assessed by qPCR. A DNA fragment
from the rho gene served as a loading control. All experiments were performed in
technical triplicates for each of three biological replicates. The primer sequences
can be found in Supplementary Table 2.
RNA isolation and reverse transcription. Bacterial cells were grown in M9MM to
late exponential growth phase cultures (OD600 ~0.8). An aliquot of 800 μL of
bacterial culture was then stabilized with RNAprotect Bacteria Reagent (QIAGEN)
and total RNA extracted using RNeasy Mini Kit (QIAGEN) according to the
manufacturer’s instructions. Traces of contaminating DNA were removed from
isolated RNA using the Turbo DNA-free kit (Ambion) as per the manufacturer’s
protocol. RNA concentration and purity, determined by 260/280 and 260/230
ratios, were measured with a NanoDrop 2000 spectrophotometer. An aliquot of 1
μg of DNA-free RNA was then reverse-transcribed to cDNA using QuantiTect
Reverse Transcription kit (QIAGEN) according to the manufacturer’s instructions.
The primer sequences as well as primer efﬁciencies and amplicon sizes are listed
below. The E. coli gyrA gene was used as a reference gene as its expression did not
change across different test strains. All experiments were performed in technical
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triplicates for each of three biological replicates. Details of primers used in qPCR
experiments are given in Supplementary Table 3.
Statistics. For real-time qRT-PCR experiments, statistical differences were eval-
uated by a paired one-tailed Student’s t test on the log10 transformed data, with the
level of signiﬁcance set at p< 0.05.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author on reasonable request.
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